Nephrotic syndrome in a patient with metastatic melanoma can occur in the context of a paraneoplastic glomerulopathy or as a complica tion of treatment. New oncologic immunotherapies, including immune checkpoint inhibitors, have been frequently associated with interstitial nephritis and, in rare cases, with nephrotic syndrome. This article presents the case of a 52 -year -old man diagnosed with metastatic melanoma who was admitted with acute kidney injury and nephrotic syndrome after having started immune checkpoint inhibitors. After investigation, acute kidney injury was attributed to immunotherapy -associated acute interstitial nephritis, and nephrotic syndrome was found to be the result of AA amyloidosis, which is a rare complicatio...
We describe here a patient with a metastatic malignant melanoma displaying crescentic lesions in the...
Background: With the expanding indications and thus broader use of immune checkpoint inhibitors, cli...
Abstract Background The anti-Programmed Death receptor 1 (anti-PD-1) antibodies nivolumab and pembro...
Item does not contain fulltextINTRODUCTION: Immune checkpoint inhibitors have taken an important pla...
Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is design...
Background: Combination molecular targeted therapy with dabrafenib plus trametinib has been shown t...
Immune-checkpoint inhibitors are emerging as revolutionary drugs for certain malignancies. However, ...
Treatment with immune checkpoint inhibitors (ICIs) has improved the prognosis of patients with a num...
Background: Immune checkpoint inhibitors are changing the landscape of oncologic treatment as they a...
Copyright © 2013 Victor Gueutin et al.This is an open access article distributed under the Creative ...
Item does not contain fulltextWe describe a patient with rheumatoid arthritis (RA) who developed a n...
International audienceBackground: Immune checkpoints inhibitors have transformed the prognosis of ad...
Acute kidney injury related to ethiologies such as dehydration, drug toxicities, urate nephropathy a...
Paraneoplastic glomerulopathy has been reported in patients with malignancy.In particular, the assoc...
Background: Even though there have been many case reports on nephrotic syndrome in patients with mal...
We describe here a patient with a metastatic malignant melanoma displaying crescentic lesions in the...
Background: With the expanding indications and thus broader use of immune checkpoint inhibitors, cli...
Abstract Background The anti-Programmed Death receptor 1 (anti-PD-1) antibodies nivolumab and pembro...
Item does not contain fulltextINTRODUCTION: Immune checkpoint inhibitors have taken an important pla...
Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is design...
Background: Combination molecular targeted therapy with dabrafenib plus trametinib has been shown t...
Immune-checkpoint inhibitors are emerging as revolutionary drugs for certain malignancies. However, ...
Treatment with immune checkpoint inhibitors (ICIs) has improved the prognosis of patients with a num...
Background: Immune checkpoint inhibitors are changing the landscape of oncologic treatment as they a...
Copyright © 2013 Victor Gueutin et al.This is an open access article distributed under the Creative ...
Item does not contain fulltextWe describe a patient with rheumatoid arthritis (RA) who developed a n...
International audienceBackground: Immune checkpoints inhibitors have transformed the prognosis of ad...
Acute kidney injury related to ethiologies such as dehydration, drug toxicities, urate nephropathy a...
Paraneoplastic glomerulopathy has been reported in patients with malignancy.In particular, the assoc...
Background: Even though there have been many case reports on nephrotic syndrome in patients with mal...
We describe here a patient with a metastatic malignant melanoma displaying crescentic lesions in the...
Background: With the expanding indications and thus broader use of immune checkpoint inhibitors, cli...
Abstract Background The anti-Programmed Death receptor 1 (anti-PD-1) antibodies nivolumab and pembro...